Improving the lives of children with intellectual and developmental disabilities.

SUPPORT FOR THE ROSE F KENNEDY IDDRC P50

NIH-funded research Albert Einstein College of Medicine · NIH-11184411

This study is all about finding new ways to improve the lives of children with intellectual and developmental disabilities by using advanced research techniques and resources, so they can have better support and opportunities.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionAlbert Einstein College of Medicine NIH-funded
Lab location1 site (Bronx, United States)
Project IDNIH-11184411 on NIH RePORTER

What this research studies

This research focuses on enhancing the quality of life for children with intellectual and developmental disabilities (IDDs) through a comprehensive approach that includes basic, translational, and clinical research. The Rose F. Kennedy Intellectual and Developmental Disabilities Research Center utilizes four specialized cores: a clinical translational core for participant access and characterization, a neurogenomics facility for advanced genetic analysis, a neural cell engineering and imaging facility for brain cell studies, and an animal phenotyping facility to evaluate behaviors and conditions in animal models. By integrating these resources, the center aims to develop innovative strategies and interventions for children affected by IDDs.

Who could benefit from this research

Good fit: Ideal candidates for participation include children aged 0-11 years diagnosed with conditions such as 22q11 deletion syndrome or autism spectrum disorder.

Not a fit: Patients with intellectual and developmental disabilities outside the specified age range or without the targeted diagnoses may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments and interventions for children with intellectual and developmental disabilities.

How similar studies have performed: Previous research at similar centers has shown significant advancements in understanding and treating intellectual and developmental disabilities, indicating a strong potential for success in this initiative.

Where this research is happening

Bronx, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions 22q11 Chromosomal Microdeletion Syndrome22q11 Deletion Syndrome22q11.2 deletion syndrome
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.